Literature DB >> 19050373

Perceived stress, severity of asthma, and quality of life in young adults with asthma.

Tomoaki Kimura1, Akihito Yokoyama, Nobuoki Kohno, Hiroyuki Nakamura, Akira Eboshida.   

Abstract

BACKGROUND: People suffering from asthmatic symptoms have a lower quality of life than those without. The aim of this study is to clarify the association of quality of life with the severity of asthma, perceived stress, and other factors such as the comorbidity of allergic diseases among young adults with asthma.
METHODS: The study participants were 695 asthma patients, aged 20-44 years, from 29 medical centers in Japan. We excluded from the analysis of the result of the study 116 patients with complications of serious diseases, cough-variant asthma or aspirin-intolerant asthma. The patients completed the 8-Item Short-Form Health Survey (SF-8), the Airways Questionnaire 20 (AQ20), and the Japanese version of the Perceived Stress Scale (JPSS) and their doctors also provided clinical information including diagnosis, complications, severity of asthma, and results of pulmonary function and immunological tests.
RESULTS: There was a weak correlation between the generic quality of life (SF-8) and the disease-specific quality of life (AQ20). The AQ 20 revealed almost no association with the results of pulmonary function and immunological tests, and only a slight association with comorbidity of allergic rhinitis and food allergy. The AQ20 showed a moderate relation with perceived stress (JPSS) but a weak association with the severity of asthma. The multiple logistic models demonstrated that there was no relationship between the severity of asthma and the AQ20 in females, and in the age group of 20-34 years.
CONCLUSIONS: A major variable related to the disease-specific quality of life was perceived stress, followed by the severity of asthma. Stress management of patients with asthma may improve their quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 19050373     DOI: 10.2332/allergolint.O-07-531

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  7 in total

1.  Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.

Authors:  Byung-Jin Kim; Harlan P Jones
Journal:  Brain Behav Immun       Date:  2010-05-31       Impact factor: 7.217

Review 2.  Asthma outcomes: quality of life.

Authors:  Sandra R Wilson; Cynthia S Rand; Michael D Cabana; Michael B Foggs; Jill S Halterman; Lynn Olson; William M Vollmer; Rosalind J Wright; Virginia Taggart
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

3.  Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome.

Authors:  Yoshinobu Mizuno; Masakazu Yamada; Yozo Miyake
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

4.  Corticotropin-releasing hormone receptor-1 and 2 activity produces divergent resistance against stress-induced pulmonary Streptococcus pneumoniae infection.

Authors:  Byung-Jin Kim; Kay Kayembe; Jerry W Simecka; Mark Pulse; Harlan P Jones
Journal:  J Neuroimmunol       Date:  2011-07-20       Impact factor: 3.478

5.  Cross-sectional study of cognitive stress appraisal and related factors among workers in metropolitan areas of Japan.

Authors:  Natsuka Tohmiya; Etsuko Tadaka; Azusa Arimoto
Journal:  BMJ Open       Date:  2018-06-19       Impact factor: 2.692

6.  Factors associated with health-related quality of life in adults with asthma. A cross-sectional study.

Authors:  Francisco-Javier Gonzalez-Barcala; Ramon de la Fuente-Cid; Mónica Tafalla; Javier Nuevo; Francisco Caamaño-Isorna
Journal:  Multidiscip Respir Med       Date:  2012-10-02

7.  A mixed-methods analysis of younger adults' perceptions of asthma, self-management, and preventive care: "This isn't helping me none".

Authors:  Jennifer R Mammen; Kelsey Turgeon; Ashley Philibert; Judith D Schoonmaker; James Java; Jill Halterman; Marc N Berliant; Amber Crowley; Marina Reznik; Jonathan M Feldman; Robert J Fortuna; Kimberly Arcoleo
Journal:  Clin Exp Allergy       Date:  2020-10-18       Impact factor: 5.018

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.